Copyright
©2011 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 21, 2011; 17(27): 3257-3262
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3257
Published online Jul 21, 2011. doi: 10.3748/wjg.v17.i27.3257
Table 1 Characteristics of population from the three periods (n = 1604)
| Characteristics | 1980s (n = 496) | 1990s (n = 673) | 2000s (n = 435) | P value |
| Age (yr) | 0.000 | |||
| Median | 56 | 60 | 58 | |
| Sex (%) | 0.000 | |||
| Male | 397 (80) | 469 (70) | 306 (70) | |
| Female | 99 (20) | 204 (30) | 129 (30) | |
| Number of lymph nodes removed | 0.000 | |||
| Mean | 12 | 12 | 18 | |
| Number of involved lymph nodes | 0.072 | |||
| Mean | 2 | 2 | 3 | |
| Tumor size (cm) | 0.000 | |||
| Median | 6 | 5 | 5 | |
| Site of tumor (%) | 0.000 | |||
| Whole stomach | 60 (12) | 49 (7) | 23 (5) | |
| Upper stomach | 55 (11) | 80 (12) | 44 (10) | |
| Middle stomach | 39 (8) | 69 (10) | 49 (11) | |
| Lower stomach | 213 (43) | 298 (44) | 254 (58) | |
| > 2/3 stomach | 129 (26) | 177 (26) | 65 (15) | |
| Pathological tumor stage (%) | 0.003 | |||
| T1 | 99 (20) | 148 (22) | 104 (24) | |
| T2 | 179 (36) | 215 (32) | 121 (28) | |
| T3 | 154 (31) | 242 (36) | 178 (41) | |
| T4 | 64 (13) | 68 (10) | 32 (7) | |
| Pathological nodal stage (%) | 0.006 | |||
| N0 | 159 (32) | 195 (29) | 152 (35) | |
| N1 | 193 (39) | 269 (40) | 161 (37) | |
| N2 | 84 (17) | 155 (23) | 94 (22) | |
| N3 | 60 (12) | 54 (8) | 28 (6) | |
| TNM stage (%) | 0.000 | |||
| IA | 47 (10) | 58 (9) | 36 (8) | |
| IB | 62 (13) | 102 (15) | 98 (23) | |
| II | 81 (16) | 168 (25) | 100 (23) | |
| IIIA | 108 (22) | 149 (22) | 86 (20) | |
| IIIB | 73 (15) | 71 (11) | 42 (10) | |
| IV | 125 (25) | 125 (19) | 73 (17) | |
| Gross type (%) | 0.000 | |||
| Borrmann I | 15 (3) | 5 (1) | 2 (1) | |
| Borrmann II | 158 (35) | 97 (16) | 44 (11) | |
| Borrmann III | 227 (50) | 439 (71) | 311 (77) | |
| Borrmann IV | 50 (11) | 79 (13) | 47 (12) | |
| Surgery (%) | 0.000 | |||
| Absolutely curative | 277 (56) | 357 (53) | 172 (40) | |
| Relatively curative | 47 (10) | 163 (24) | 225 (52) | |
| Palliative | 172 (35) | 153 (23) | 38 (9) | |
| Lymph node dissection (%) | 0.000 | |||
| D1 | 51 (10) | 52 (8) | 46 (11) | |
| D2 | 188 (38) | 399 (59) | 347 (80) | |
| D3 | 90 (18) | 73 (11) | 16 (4) | |
| Palliative resection | 167 (34) | 149 (22) | 26 (6) | |
| Complication (%) | 0.001 | |||
| Intestinal obstruction | 16 (3) | 7 (1) | 11 (3) | |
| Anastomotic leakage | 10 (2) | 12 (2) | 0 (0) | |
| Pneumonia | 3 (1) | 3 (0) | 1 (0) | |
| Abdominal abscess | 8 (2) | 11 (2) | 7 (2) | |
| Anemia | 3 (1) | 1 (0) | 4 (1) | |
| Other | 7 (1) | 12 (2) | 22 (5) | |
| Hepatic metastasis (%) | 21 (4) | 21 (3) | 10 (2) | 0.244 |
| Peritoneum metastasis (%) | 67 (14) | 50 (7) | 25 (6) | 0.000 |
| Adjunctive therapy (%) | 0 (0) | 41 (6) | 153 (35) | 0.000 |
| Type of gastrectomy (%) | 0.073 | |||
| Total | 94 (19) | 95 (14) | 76 (17) | |
| Subtotal | 402 (81) | 578 (86) | 359 (83) | |
| Combined organ resection | 0.000 | |||
| Pancreas or spleen | 53 (11) | 56 (8) | 18 (4) | |
| Liver or gall | 11 (2) | 12 (2) | 19 (4) | |
| Transverse colon | 20 (4) | 51 (8) | 52 (12) | |
| Other | 15 (3) | 20 (3) | 12 (3) |
Table 2 HR for death in population (n =1604) - univariable and multivariable analyses
| Univariable analyses | Multivariable analyses | |||
| HR (95% CI) | P | HR (95% CI) | P | |
| Age (yr) | 0 | 0.005 | ||
| ≤ 55 | 1 (Ref) | 1 (Ref) | ||
| > 55 | 1.383 (1.222-1.565) | 0 | 1.240 (1.036-1.484) | 0.019 |
| Sex | 0.734 | 0.582 | ||
| Male | 1 (Ref) | 1 (Ref) | ||
| Female | 0.977 (0.855-1.117) | 0.734 | 1.030 (0.854-1.241) | 0.760 |
| Tumor size | 0 | 0.024 | ||
| ≤ 5 cm | 1 (Ref) | 1 (Ref) | ||
| 5-7 cm | 1.782 (1.534-2.071) | 0 | 1.250 (1.006-1.553) | 0.044 |
| > 7 cm | 2.587 (2.244-2.982) | 0 | 1.211 (0.956-1.533) | 0.113 |
| Tumor site | 0 | 0.071 | ||
| Whole stomach | 1 (Ref) | 1 (Ref) | ||
| Upper stomach | 0.625 (0.489-0.798) | 0 | 1.247 (0.825-1.886) | 0.295 |
| Middle stomach | 0.358 (0.273-0.471) | 0 | 0.844 (0.541-1.315) | 0.453 |
| Lower stomach | 0.401 (0.327-0.490) | 0 | 0.846 (0.574-1.247) | 0.399 |
| > 2/3 stomach | 0.588 (0.475-0.727) | 0 | 0.845 (0.590-1.210) | 0.358 |
| Gross appearance | 0 | 0.002 | ||
| Borrmann types I | 1 (Ref) | 1 (Ref) | ||
| Borrmann types II | 0.541 (0.338-0.867) | 0.011 | 0.405 (0.179-0.915) | 0.030 |
| Borrmann types III | 0.807 (0.510-1.278) | 0.361 | 0.626 (0.284-1.381) | 0.246 |
| Borrmann types IV | 1.357 (0.841-2.191) | 0.211 | 1.328 (0.317-1.672) | 0.454 |
| Tumor stage | 0 | 0.408 | ||
| T1 | 1 (Ref) | 1 (Ref) | ||
| T2 | 3.336 (2.542-4.377) | 0 | 1.458 (0.797-2.667) | 0.221 |
| T3 | 4.275 (3.218-5.678) | 0 | 1.780 (0.510-2.287) | 0.841 |
| T4 | 7.873 (5.689-10.894) | 0 | 1.991 (0.459-2.590) | 0.844 |
| Lymph-node stage | 0 | 0.874 | ||
| N0 | 1 (Ref) | 1 (Ref) | ||
| N1 | 2.980 (2.411-3.682) | 0 | 1.176 (0.913-2.073) | 0.127 |
| N2 | 3.430 (2.754-4.271) | 0 | 1.443 (0.595-1.826) | 0.883 |
| N3 | 5.174 (3.934-6.804) | 0 | 1.756 (0.324-2.766) | 0.518 |
| TNM stage | 0 | 0.019 | ||
| IA | 1 (Ref) | 1 (Ref) | ||
| IB | 1.920 (1.381-2.671) | 0 | 0.642 (0.288-1.431) | 0.279 |
| II | 2.645 (1.938-3.608) | 0 | 0.779 (0.293-2.068) | 0.616 |
| IIIA | 4.306 (3.171-5.847) | 0 | 1.303 (0.429-3.961) | 0.641 |
| IIIB | 4.847 (3.510-6.693) | 0 | 1.459 (0.409-5.204) | 0.561 |
| IV | 8.982 (6.613-12.199) | 0 | 3.286 (0.779-13.857) | 0.105 |
| Surgery | 0 | 0 | ||
| Absolutely curative | 1 (Ref) | 1 (Ref) | ||
| Relatively curative | 1.907 (1.631-2.230) | 0 | 1.372 (1.114-1.690) | 0.003 |
| Palliative | 4.368 (3.782-5.044) | 0 | 3.361 (1.752-6.448) | 0 |
| Lymph node dissection | 0 | 0.867 | ||
| D1 | 1 (Ref) | 1 (Ref) | ||
| D2 | 0.931 (0.750-1.155) | 0.515 | 1.169 (0.821-1.664) | 0.387 |
| D3 | 0.807 (0.616-1.058) | 0.121 | 1.146 (0.738-1.780) | 0.543 |
| Palliative resection | 3.236 (2.573-4.070) | 0 | 1.359 (0.457-1.612) | 0.636 |
| Joint organ removal | 0 | 0.007 | ||
| None | 1 (Ref) | 1 (Ref) | ||
| Pancreas or spleen | 1.997 (1.640-2.433) | 0 | 1.086 (0.709-1.372) | 0.933 |
| Liver or gall | 1.514 (1.029-2.227) | 0.035 | 1.108 (0.649-1.891) | 0.707 |
| Transverse colon | 2.093 (1.699-2.579) | 0 | 1.466 (1.107-1.942) | 0.008 |
| Other | 2.453 (1.797-3.350) | 0 | 1.008 (0.586-1.731) | 0.978 |
| Gastrectomy | 0 | 0.512 | ||
| Total | 1 (Ref) | 1 (Ref) | ||
| Subtotal | 0.573 (0.494-0.664) | 0 | 0.912 (0.693-1.200) | 0.511 |
| Hepatic metastasis | 0 | 0.796 | ||
| No | 1 (Ref) | 1 (Ref) | ||
| Yes | 4.002 (2.991-5.354) | 0 | 1.285 (0.403-1.529) | 0.476 |
| Peritoneum metastasis | 0 | 0.947 | ||
| No | 1 (Ref) | 1 (Ref) | ||
| Yes | 2.835 (2.359-3.406) | 0 | 1.127 (0.382-1.381) | 0.329 |
| Complication | 0.41 | 0.157 | ||
| None | 1 (Ref) | 1 (Ref) | ||
| Intestinal obstruction | 0.796 (0.522-1.216) | 0.292 | 1.311 (0.670-2.565) | 0.428 |
| Anastomotic leakage | 1.474 (0.946-2.294) | 0.086 | 1.893 (0.904-3.965) | 0.091 |
| Pneumonia | 1.069 (0.400-2.856) | 0.894 | 1.207 (0.323-4.525) | 0.929 |
| Abdominal abscess | 1.212 (0.795-1.850) | 0.372 | 1.295 (0.700-2.397) | 0.410 |
| Anaemia | 0.487 (0.157-1.514) | 0.214 | 0.479 (0.116-1.980) | 0.309 |
| Other | 0.702 (0.421-1.172) | 0.176 | 0.488 (0.240-0.992) | 0.047 |
| Adjunctive therapy | 0.022 | 0.364 | ||
| No | 1 (Ref) | 1 (Ref) | ||
| Yes | 0.744 (0.577-0.959) | 0.022 | 0.850 (0.643-1.124) | 0.254 |
| Diagnosis period | 0.395 | 0.385 | ||
| 1980s | 1 (Ref) | 1 (Ref) | ||
| 1990s | 1.072 (0.937-1.226) | 0.311 | 1.025 (0.807-1.301) | 0.840 |
| 2000s | 0.884 (0.735-1.063) | 0.191 | 0.914 (0.674-1.241) | 0.565 |
- Citation: Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B. Survival trends in gastric cancer patients of Northeast China. World J Gastroenterol 2011; 17(27): 3257-3262
- URL: https://www.wjgnet.com/1007-9327/full/v17/i27/3257.htm
- DOI: https://dx.doi.org/10.3748/wjg.v17.i27.3257
